Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study

MT Newswires Live

02/02

Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.

The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.

Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2608827108"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2608827108\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2608827108?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-02 07:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608827108","market":"sg","top_or_hot":-1,"title":"Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study","media":"MT Newswires Live","content":"<html><body><p> Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.</p><p>The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.</p><p>Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Artrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArtrya Says US Health System Agrees to In-Principle Participation in Cardiovascular Study\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-02-02 07:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.</p><p>The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.</p><p>Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2608827108","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608827108","pubTimestamp":1769988773,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Artrya  said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK7094":"医疗保健技术","AYA.AU":"ARTRYA LTD","CSII":"Cardiovascular Systems"},"translate_title":"Artrya表示美国卫生系统原则上同意参与心血管研究","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AYA.AU":1,"CSII":1.5},"content_text":"Artrya (ASX:AYA) said Dignity Health Arizona agreed to in-principle participation in the retrospective US multi-center SAPPHIRE Study, according to a Monday filing with the Australian bourse.The study will evaluate the clinical and prognostic value of the Salix plaque analysis and its plaque dispersion score to identify patients at elevated risk of cardiovascular events, the filing said.Additionally, the company plans to focus its upcoming study on women with coronary artery disease, which will include a group of women-only patients at risk, known as SAPPHIRE-WIN, per the filing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}